Analystreport

Ironwood Pharmaceuticals (NASDAQ:IRWD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com